Global /China /Healthcare /Drug Manufacturers - General /000790

Chengdu huasun technology group Inc. , LTD.

000790

• SHE: 000790 • Delayed

4.57CNY 10%

0.6753 USD

As of 15 June 2026, Chengdu huasun technology group Inc. , LTD. has a market cap of $382.0M USD, ranking #16995 globally and #5293 in China. It ranks #1538 in the Healthcare sector, and #555 in the Drug Manufacturers - General industry.

Global Rank

16995

Country Rank

5293

Sector Rank

1538

Industry Rank

555

Key Stats

Market Cap

$382.0MUSD

2.59B CNY

Enterprise Value

$419.01MUSD

2.84B CNY

Revenue (TTM)

$80.5MUSD

545.5M CNY

EBITDA (TTM)

-$10.21MUSD

-69.08M CNY

Net Income (TTM)

-$47.29MUSD

-320.42M CNY

EBITDA Margin

-13%

Profit Margin

-59%

PS Ratio

4.7

PB Ratio

3.7

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mingliang Huang open_in_new

Employees

727

Founded

1988

Website

huasungrp.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
10%	19%	12%	15%	16%	18%	31%	0.2%	-22%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000790 成都华神科技集团股份有限公司 Class A ISIN: CNE0000001H5 Shares Out.: Shares Outstanding: 623.719M¹ Shares Float: 510.845M² TV: TradingView: SZSE: 000790 SA: Stock Analysis: SHE: 000790 YF: Yahoo Finance: 000790.SZ GF: Google Finance: SHE: 000790 BA: Barron's: 000790 MS: Morningstar: XSHE: 000790	4.57 CNY	TV: TradingView: SZSE: 000790 SA: Stock Analysis: SHE: 000790 YF: Yahoo Finance: 000790.SZ GF: Google Finance: SHE: 000790 BA: Barron's: 000790 MS: Morningstar: XSHE: 000790

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chengdu huasun technology group Inc. , LTD.

Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs, as well as medicines for the treatment of cardiovascular and cerebrovascular diseases. In addition, the company designs, produces, installs, and services steel structure buildings. The company was formerly known as Chengdu Taihe Health Technology Group Inc., Ltd. and changed its name to Chengdu huasun technology group Inc. , LTD. in April 2020. The company was founded in 1988 and is based in Chengdu, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 14K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 13K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 199K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 143K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 94K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 84K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 76K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 72K%	20.5	Switzerland

chevron_leftBack